K. Ault
Proceedings of the National Academy of Sciences of the United States of America · 2002–2010
A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Whom K. Ault trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Ault overall
Papers from K. Ault's perspective
Ordered by how strongly the researchers K. Ault trusts endorse each paper. Same corpus, a different order for every researcher.
- HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
- Nonparametric Estimation from Incomplete Observations
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns
- Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (New England Journal of Medicine)
- Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex (Nature Methods)
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy (Applied and Environmental Microbiology)
- Bacterial Community Variation in Human Body Habitats Across Space and Time (Science)
- The causal relation between human papillomavirus and cervical cancer. (Journal of Clinical Pathology)
Their papers
- Vaginal microbiome of reproductive-age women (2010) — 3,811 citations
- Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) — 638 citations
- Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. (2007) — 627 citations
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) — 1,759 citations
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. (2005) — 1,716 citations
- A controlled trial of a human papillomavirus type 16 vaccine. (2002) — 1,817 citations